The viscosupplementation market is gaining attention as more patients seek non-surgical treatment options for knee osteoarthritis (OA). Viscosupplementation involves injecting hyaluronic acid into the knee joint to improve lubrication and support movement. As a result, the treatment can help some patients manage knee pain and stiffness.
Hyaluronic acid naturally occurs in synovial fluid. This fluid cushions the knee and helps absorb shock during walking, running, twisting, and other movements. However, people with knee osteoarthritis may have lower levels of hyaluronic acid in the joint. This can reduce natural lubrication and increase stress on cartilage and bone.
Market Outlook
The viscosupplementation market is supported by the growing need for knee osteoarthritis treatment. OA can make everyday activities difficult by causing pain, stiffness, and reduced movement. As a result, patients and healthcare providers continue to consider different treatment approaches.
Viscosupplementation mainly uses hyaluronic acid, also called hyaluronate or hyaluron. The injection is intended to improve joint lubrication and support smoother movement.
Patients receiving these injections may also be advised to follow a rehabilitation program. Gentle and progressive knee exercises can help improve muscle strength and range of motion. In addition, stronger muscles can provide better support for the knee joint.
Rising Knee Osteoarthritis Cases Drive Demand
The growing burden of knee osteoarthritis is an important factor supporting the market. OA can affect mobility and make activities such as walking, climbing stairs, and exercising more difficult.
Patients who do not receive enough relief from medicines, physical therapy, or other non-surgical treatments may consider viscosupplementation. Therefore, demand for minimally invasive treatment options can support market growth.
Moreover, the need for better mobility among patients with knee problems can encourage the use of treatments designed to reduce discomfort and improve joint movement.
Hyaluronic Acid Supports Joint Lubrication
Hyaluronic acid plays an important role in normal joint function. It helps make synovial fluid thick and lubricating. As a result, the fluid allows the bones within the joint to move more smoothly.
In an arthritic knee, adding hyaluronic acid is intended to restore some of the joint’s lubricating properties. This may help reduce friction and support movement.
However, treatment outcomes can vary between patients. Some people may experience meaningful relief, while others may see limited improvement. Therefore, doctors generally consider the patient’s condition and previous treatment response before recommending viscosupplementation.
Commercial Viscosupplement Options
Several hyaluronic acid products are available for viscosupplementation. These products differ in their formulations, injection schedules, and treatment courses.
Commonly discussed options include:
Hyalgan: Administered as a five-injection course, with one injection generally given each week.
Euflexxa: Typically administered as three injections over three weeks.
Orthovisc: Available in three- or four-injection treatment schedules and produced using bacterial cells.
Supartz: Available in different injection schedules, including three- and five-dose courses.
Synvisc-One: Designed as a single-injection viscosupplement option.
Treatment Schedules Create Product Opportunities
The number of injections required can differ between viscosupplement products. Some treatments require several weekly injections, while others are designed to provide treatment through a single injection.
Single-dose products can offer convenience for patients and healthcare providers. Similarly, multi-dose products can provide different treatment approaches based on clinical requirements.
Non-Surgical Treatment Supports Market Growth
Many patients prefer to explore non-surgical options before considering more invasive procedures. Viscosupplementation provides one such option for selected knee OA patients.
The treatment involves an injection into the affected joint rather than surgical replacement of the knee. As a result, it can appeal to patients seeking alternatives before moving toward surgical treatment.
Safety and Side Effects Remain Important
Safety is an important consideration in the viscosupplementation market. Patients may experience temporary reactions after receiving an injection.
Common side effects can include:
Knee swelling
Joint pain
Redness
Tenderness
Injection-site irritation
Stiffness
Joint effusion
Skin reactions
In addition, rare but serious allergic reactions can occur. Symptoms such as hives, difficulty breathing, throat closing, or swelling of the lips, tongue, or face require urgent medical attention.
Therefore, patients should discuss allergies and previous reactions with their healthcare providers before receiving treatment.
Long-Term Effectiveness Remains a Challenge
Long-term treatment outcomes remain an important consideration for the market. While some patients report pain relief after viscosupplementation, clinical responses can differ.
Research has not established that viscosupplementation provides the same level of benefit for every patient. As a result, doctors need to consider individual patient factors when selecting treatment options.
Growth Opportunities
The market offers growth opportunities as patients and healthcare providers continue to explore non-surgical approaches to knee osteoarthritis.
Key opportunities include:
Single-dose viscosupplement products
Multi-dose hyaluronic acid treatments
Advanced hyaluronic acid formulations
Patient-friendly injection schedules
Non-surgical knee OA management
Products designed for improved treatment convenience
Continued research into long-term outcomes
Moreover, product development can focus on improving treatment consistency and patient experience.
Market Challenges
The viscosupplementation market also faces several challenges. Treatment results can vary between patients. In addition, some patients may not experience significant pain relief or improved joint function.
Safety concerns can also affect treatment decisions. Allergic reactions and local injection-site effects require careful consideration.
Competitive Landscape and Future Outlook
Competition in the viscosupplementation market centers on product formulation, treatment schedules, patient convenience, safety, and clinical evidence. Companies offering different injection options can address varying healthcare provider and patient needs.
Single-injection products may attract patients seeking greater convenience. Meanwhile, multi-dose products can continue to serve patients who require different treatment schedules.
Furthermore, research into hyaluronic acid formulations and improved delivery approaches may create new opportunities for market participants.
Conclusion
The viscosupplementation market is gaining importance as knee osteoarthritis continues to affect mobility and quality of life. Hyaluronic acid injections can help improve joint lubrication and may provide pain relief for some patients.
The availability of different products and dosing schedules gives healthcare providers multiple treatment options. However, patient responses vary, and long-term effectiveness remains an area of continued research.
Explore More Related Studies Published by FMI Research:
Fucosidosis Therapeutics Market: https://www.openpr.com/news/4534916/fucosidosis-therapeutics-market-driven-by-north-america-as
PPG Biosensors Market: https://www.openpr.com/news/4534926/ppg-biosensors-market-led-by-united-states-as-medtronic-plc
Ringworm Treatment Market: https://www.openpr.com/news/4534932/ringworm-treatment-market-led-by-south-korea-as-bayer-ag
FMI Custom Research: Strategic Intelligence for Confident Decision-Making
In today’s rapidly evolving business environment, leadership teams need more than market data—they need clear, actionable intelligence tailored to their strategic objectives. FMI’s Custom Research solutions are designed around the specific business questions organizations need answered, enabling executives to evaluate growth opportunities, validate investments, assess competitive dynamics, and reduce uncertainty before making critical decisions. By combining deep industry expertise, primary research, and proprietary market intelligence, FMI delivers insights that help organizations move from assumptions to evidence-based strategies with greater speed and confidence.
Key Executive Benefits
Decision-Ready Insights: Research tailored to your specific business challenges, growth plans, and investment priorities.
Reduced Strategic Risk: Validate market opportunities, customer demand, and competitive positioning before committing resources.
Market Entry Confidence: Assess opportunity size, regulatory barriers, channel dynamics, and competitive landscapes with precision.
Competitive Advantage: Gain proprietary intelligence unavailable through syndicated reports or internal datasets.
Faster Growth Decisions: Accelerate expansion, product development, portfolio optimization, and investment planning.
Primary Market Validation: Access real-world customer, buyer, and stakeholder insights that support high-confidence decision-making.
Global Industry Expertise: Powered by 100+ analysts, 20,000+ published reports, and 1.6 million+ hours of research experience.
Proven Track Record: Over 7,000 market-entry engagements completed across six regions and 14 industry sectors with strong client retention.
Business Impact
FMI helps organizations transform market complexity into strategic clarity, enabling leadership teams to identify growth opportunities faster, optimize resource allocation, strengthen competitive positioning, and make high-stakes business decisions with confidence.
To explore how FMI Custom Research can support your strategic priorities, please connect with our team at – sales@futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights is a leading provider of market intelligence, consulting services, and syndicated research reports. FMI delivers actionable insights across food and beverage, healthcare, consumer goods, biotechnology, chemicals, industrial products, and emerging technologies, helping organizations identify growth opportunities and make informed strategic decisions in evolving global markets.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Why FMI: https://www.futuremarketinsights.com/why-fmi
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
